Association of lipid profile and BMI Z-score in southern Iranian children and adolescents
-
Ashkan Habib
Abstract
Background
Heart disease has been the leading cause of death for decades in the US population. Dyslipidemia is the most important risk factor for cardiovascular disease (CVD), and it often starts during childhood.
Methods
This cross-sectional study was performed in a growth assessment clinic in the city of Shiraz to determine the relation between body mass index (BMI) and dyslipidemia among children and teenagers aged 2–18 years. Nine hundred and eighty-nine children including 422 boys and 567 girls were selected.
Results
Adjusted for age and gender, total cholesterol (TC) (r = 0.172, p = 0.000), low-density lipoprotein cholesterol (LDL-c) (r = 0.176, p = 0.000), non-high-density lipoprotein cholesterol (non-HDL-c) (r = 0.227, p = 0.000) and triglycerides (TG) (r = 0.253, p = 0.000) showed a significant positive correlation with BMI Z-score, and HDL-c showed a significant negative correlation with BMI Z-score (r = −0.131, p = 0.000). Adjusted for age and gender, overweight and obese children were 1.882 times more likely to have high TC levels (p = 0.009), 2.236 times more likely to have high non-HDL-c levels (p = 0.000) and 3.176 times more likely to have high TG levels (p = 0.000) in comparison with children who had a healthy weight. Obese children had the highest percentage of isolated TG dyslipidemia (23.1%) and underweight children had the highest percentage of isolated HDL dyslipidemia (15.6%).
Conclusions
There is a strong link between atherosclerotic cardiovascular disease (ASCVD) and the level of blood lipids and between blood lipids and BMI Z-score. The first step in preventing ASCVD is the reduction of blood lipids, preventing weight gain and loss of extra weight.
Acknowledgments
The authors are grateful to individuals who participated in this survey and to Boghrat Laboratory for assisting in biochemical tests.
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organizations played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
References
1. National Center for Health Statistics. Leading causes of death, 1900–1998. 2000. Available at: http://www.cdc.gov/nchs/data/dvs/lead1900_98.pdf.Search in Google Scholar
2. World Health Organization. The top 10 causes of death in 2016. Available at: http://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death.Search in Google Scholar
3. National Research Council (US) Committee on Diet and Health. Diet and health: implications for reducing chronic disease risk. Atherosclerotic Cardiovascular Diseases. Washington, DC: National Academies Press (US) 1989:19. Available at: https://www.ncbi.nlm.nih.gov/books/NBK218744/.Search in Google Scholar
4. Daniels SR, Greer FR, Committee on Nutrition. Lipid screening and cardiovascular health in childhood. Pediatrics 2008;122:198–208.10.1542/peds.2008-1349Search in Google Scholar PubMed
5. Webber LS, Srinivasan SR, Wattigney WA, Berenson GS. Tracking of serum lipids and lipoproteins from childhood to adulthood. The Bogalusa Heart Study. Am J Epidemiol 1991;133:884–99.10.1093/oxfordjournals.aje.a115968Search in Google Scholar PubMed
6. Lozano P, Henrikson NB, Morrison CC, Dunn J, Nguyen M, et al. Lipid screening in childhood and adolescence for detection of multifactorial dyslipidemia: evidence report and systematic review for the US Preventive Services Task Force. J Am Med Assoc 2016;316:634–44.10.1001/jama.2016.6423Search in Google Scholar PubMed
7. Li S, Chen W, Srinivasan SR, Bond MG, Tang R, et al. Childhood cardiovascular risk factors and carotid vascular changes in adulthood: the Bogalusa Heart Study. J Am Med Assoc 2003;290:2271–6.10.1001/jama.290.17.2271Search in Google Scholar PubMed
8. World Health Organization. Obesity: preventing and managing the global epidemic. World Health Organ Tech Rep Ser 894. Geneva: World Health Organization, 2000.Search in Google Scholar
9. Simmonds M, Llewellyn A, Owen CG, Woolacott N. Predicting adult obesity from childhood obesity: a systematic review and meta-analysis. Obes Rev 2016;17:95–107.10.1111/obr.12334Search in Google Scholar PubMed
10. Nuotio J, Pitkänen N, Magnussen CG, Buscot MJ, Venäläinen MS, et al. Prediction of adult dyslipidemia using genetic and childhood clinical risk factors: the Cardiovascular Risk in Young Finns Study. Circ Cardiovasc Genet 2017;10.10.1161/CIRCGENETICS.116.001604Search in Google Scholar PubMed
11. Kumar S, Kelly AS. Review of childhood obesity: from epidemiology, etiology, and comorbidities to clinical assessment and treatment. Mayo Clin Proc 2017;92:251–65.10.1016/j.mayocp.2016.09.017Search in Google Scholar PubMed
12. Centers for Disease Control and Prevention (CDC). Prevalence of abnormal lipid levels among youths – United States, 1999–2006. MMWR Morb Mortal Wkly Rep 2010;59:29–33.Search in Google Scholar
13. Rajjo T, Almasri J, Al Nofal A, Farah W, Alsawas M, et al. The association of weight loss and cardiometabolic outcomes in obese children: systematic review and meta-regression. J Clin Endocrinol Metab 2017;102:758–62.10.1210/jc.2016-2575Search in Google Scholar PubMed
14. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, National Heart, Lung, and Blood Institute. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics 2011; 128(Suppl 5):S213–56.10.1542/peds.2009-2107CSearch in Google Scholar PubMed PubMed Central
15. Dai S, Yang Q, Yuan K, Loustalot F, Fang J, et al. Non-high-density lipoprotein cholesterol: distribution and prevalence of high serum levels in children and adolescents: United States National Health and Nutrition Examination Surveys, 2005–2010. J Pediatr 2014;164:247.10.1016/j.jpeds.2013.08.069Search in Google Scholar PubMed PubMed Central
16. Kit BK, Carroll MD, Lacher DA, Sorlie PD, Dejesus JM, et al. Trends in serum lipids among US youths aged 6–19 years, 1988–2010. J Am Med Assoc 2012;308:591–600.10.1001/jama.2012.9136Search in Google Scholar PubMed
17. Cook S, Kavey RE. Dyslipidemia and pediatric obesity. Pediatr Clin North Am 2011;58:1363–73, ix.10.1016/j.pcl.2011.09.003Search in Google Scholar PubMed PubMed Central
18. Azizi F, Rahmani M, Madjid M, Allahverdian S, Ghanbili J, et al. Serum lipid levels in an Iranian population of children and adolescents: Tehran lipid and glucose study. Eur J Epidemiol 2001;17:281–8.10.1023/A:1017932212350Search in Google Scholar
19. Toprak D, Bukulmez A, Dogan N, Oztekin O, Koken T. Evaluation of serum lipid profiles in Turkish children aged 2–18 years. West Indian Med J 2014;63:588–95.10.7727/wimj.2013.063Search in Google Scholar
20. Nielsen TR, Lausten-Thomsen U, Fonvig CE, Bøjsøe C, PedersenL, et al. Dyslipidemia and reference values for fasting plasma lipid concentrations in Danish/North-European White children and adolescents. BMC Pediatr 2017;17:116.10.1186/s12887-017-0868-ySearch in Google Scholar PubMed PubMed Central
21. Friedland O, Nemet D, Gorodnitsky N, Wolach B, Eliakim A. Obesity and lipid profiles in children and adolescents. J Pediatr Endocrinol Metab 2002;15:1011–6.10.1515/JPEM.2002.15.7.1011Search in Google Scholar PubMed
22. Zhang CX, Tse LA, Deng XQ, Jiang ZQ. Cardiovascular risk factors in overweight and obese Chinese children: a comparison of weight-for height index and BMI as the screening criterion. Eur J Nutr 2008;47:244–50.10.1007/s00394-008-0718-7Search in Google Scholar PubMed
23. Posadas-Sánchez R, Posadas-Romero C, Zamora-González J, Mendoza-Pérez E, Cardoso-Saldaña G, et al. Lipid and lipoprotein profiles and prevalence of dyslipidaemia in Mexican adolescents. Metabolism 2007;56:1666–72.10.1016/j.metabol.2007.07.009Search in Google Scholar PubMed
24. Gidding SS. A perspective on obesity. Am J Med Sci 1995;310(Suppl 1):S68–71.10.1097/00000441-199512000-00012Search in Google Scholar PubMed
25. Cardoso-Saldaña GC, Yamamoto-Kimura L, Medina-Urrutia A, Posadas-Sánchez R, Caracas-Portilla NA, et al. Obesity or overweight and metabolic syndrome in Mexico City teenagers. Arch Cardiol Mex 2010;80:12–8.Search in Google Scholar
26. Pereira A, Guedes AD, Verreschi IT, Santos RD, Martinez TL. Obesity and its association with other cardiovascular risk factors in school children in Itapetininga, Brazil. Arq Bras Cardiol 2009;93:253–60.10.1590/S0066-782X2009000900009Search in Google Scholar
27. Bibiloni Mdel M, Salas R, Novelo HI, Villarreal JZ, Sureda A, et al. Serum lipid levels and dyslipidaemia prevalence among 2–10 year-old Northern Mexican children. PLoS One 2015;10:e0119877.10.1371/journal.pone.0119877Search in Google Scholar PubMed PubMed Central
28. Klop B, Elte JW, Cabezas MC. Dyslipidemia in obesity: mechanisms and potential targets. Nutrients 2013;5:1218–40.10.3390/nu5041218Search in Google Scholar PubMed PubMed Central
29. Ding W, Cheng H, Yan Y, Zhao X, Chen F, et al. 10-Year trends in serum lipid levels and dyslipidemia among children and adolescents from several schools in Beijing, China. J Epidemiol 2016;26:637–45.10.2188/jea.JE20140252Search in Google Scholar PubMed PubMed Central
30. Harel Z, Riggs S, Vaz R, Flanagan P, Harel D. Isolated low HDL cholesterol emerges as the most common lipid abnormality among obese adolescents. Clin Pediatr (Phila) 2010;49:29–34.10.1177/0009922809341076Search in Google Scholar PubMed
31. Hamidi A, Fakhrzadeh H, Moayyeri A, Pourebrahim R, Heshmat R, et al. Obesity and associated cardiovascular risk factors in Iranian children: a cross-sectional study. Pediatr Int 2006;48:566–71.10.1111/j.1442-200X.2006.02273.xSearch in Google Scholar PubMed
32. Cohen JD, Cziraky MJ, Cai Q, Wallace A, Wasser T, et al. 30-Year trends in serum lipids among United States adults: results from the National Health and Nutrition Examination Surveys II, III, and 1999–2006. Am J Cardiol 2010;106:969–75.10.1016/j.amjcard.2010.05.030Search in Google Scholar PubMed
33. Baker JL, Olsen LW, Sorensen TI. Childhood body-mass index and the risk of coronary heart disease in adulthood. N Engl J Med 2007;357:2329–37.10.1056/NEJMoa072515Search in Google Scholar PubMed PubMed Central
34. Hernández-Valero MA, Bustamante-Montes LP, Hernández M, Halley-Castillo E, Wilkinson AV, et al. Higher risk for obesity among Mexican-American and Mexican immigrant children and adolescents than among peers in Mexico. J Immigr Minor Health 2012;14:517–22.10.1007/s10903-011-9535-9Search in Google Scholar PubMed PubMed Central
35. Vega GL. Management of atherogenic dyslipidemia of the metabolic syndrome: evolving rationale for combined drug therapy. Endocrinol Metab Clin North Am 2004;33:525–vi.10.1016/j.ecl.2004.03.013Search in Google Scholar PubMed
36. Sniderman AD, Williams K, Contois JH, Monroe HM, McQueen MJ, et al. A meta-analysis of low-density lipoprotein cholesterol, non-highdensity lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk. Circ Cardiovasc Qual Outcomes 2011;4:337–45.10.1161/CIRCOUTCOMES.110.959247Search in Google Scholar PubMed
37. Nordestgaard BG, Langsted A, Mora S, Kolovou G, Baum H, et al. Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points – a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine. Eur Heart J 2016;37:1944–58.10.1093/eurheartj/ehw152Search in Google Scholar PubMed PubMed Central
©2019 Walter de Gruyter GmbH, Berlin/Boston
Articles in the same Issue
- Frontmatter
- Mini Review
- Endocrine manifestations of PHACE syndrome
- Original Articles
- Quantitation of the arginine family amino acids in the blood of full-term infants perinatally in relation to their birth weight
- Effect of supplementation with omega-3 fatty acids on hypertriglyceridemia in pediatric patients with obesity
- Pediatric diabetes inpatient care: can medical staff knowledge be improved?
- Association of lipid profile and BMI Z-score in southern Iranian children and adolescents
- Arterial stiffness in children and adolescents with and without continuous insulin infusion
- Fasting during the holy month of Ramadan among older children and adolescents with type 1 diabetes in Kuwait
- Evaluation of the relationship between short-term glycemic control and netrin-1, a urinary proximal tubular injury marker in children with type 1 diabetes
- Incidence of diabetic ketoacidosis in newly diagnosed type 1 diabetes children in western Saudi Arabia: 11-year experience
- Novel mutations and spectrum of the disease of NR0B1 (DAX1)-related adrenal insufficiency in Indian children
- Metabolic profile, cardiovascular risk factors and health-related quality of life in children, adolescents and young adults with congenital adrenal hyperplasia
- Safety and effectiveness of growth hormone therapy in infants with Prader-Willi syndrome younger than 2 years: a prospective study
- Response to sapropterin hydrochloride (Kuvan®) in children with phenylketonuria (PKU): a clinical trial
- Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A in children: a single centre experience
- Benign thyroid nodules in pediatric patients: determining best practices for repeat ultrasound evaluations
- Letter to the Editor
- Thyroid function in males with fragile X syndrome
- Case Reports
- A case of a severe reaction following the use of bisphosphonates in a patient with osteogenesis imperfecta
- Cushing disease in a patient with nonbullous congenital ichthyosiform erythroderma: lessons in avoiding glucocorticoids in ichthyosis
- Contiguous gene deletion in a Chinese family with X-linked nephrogenic diabetes insipidus: challenges in early diagnosis and implications for affected families
Articles in the same Issue
- Frontmatter
- Mini Review
- Endocrine manifestations of PHACE syndrome
- Original Articles
- Quantitation of the arginine family amino acids in the blood of full-term infants perinatally in relation to their birth weight
- Effect of supplementation with omega-3 fatty acids on hypertriglyceridemia in pediatric patients with obesity
- Pediatric diabetes inpatient care: can medical staff knowledge be improved?
- Association of lipid profile and BMI Z-score in southern Iranian children and adolescents
- Arterial stiffness in children and adolescents with and without continuous insulin infusion
- Fasting during the holy month of Ramadan among older children and adolescents with type 1 diabetes in Kuwait
- Evaluation of the relationship between short-term glycemic control and netrin-1, a urinary proximal tubular injury marker in children with type 1 diabetes
- Incidence of diabetic ketoacidosis in newly diagnosed type 1 diabetes children in western Saudi Arabia: 11-year experience
- Novel mutations and spectrum of the disease of NR0B1 (DAX1)-related adrenal insufficiency in Indian children
- Metabolic profile, cardiovascular risk factors and health-related quality of life in children, adolescents and young adults with congenital adrenal hyperplasia
- Safety and effectiveness of growth hormone therapy in infants with Prader-Willi syndrome younger than 2 years: a prospective study
- Response to sapropterin hydrochloride (Kuvan®) in children with phenylketonuria (PKU): a clinical trial
- Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A in children: a single centre experience
- Benign thyroid nodules in pediatric patients: determining best practices for repeat ultrasound evaluations
- Letter to the Editor
- Thyroid function in males with fragile X syndrome
- Case Reports
- A case of a severe reaction following the use of bisphosphonates in a patient with osteogenesis imperfecta
- Cushing disease in a patient with nonbullous congenital ichthyosiform erythroderma: lessons in avoiding glucocorticoids in ichthyosis
- Contiguous gene deletion in a Chinese family with X-linked nephrogenic diabetes insipidus: challenges in early diagnosis and implications for affected families
